2018 Beijing Liver Cancer International Conference(BLCIC)

2018-08-09 02:14:43


Co-Sponsors: Peking University Health Science Center & NIH/NCI

Organizer: Peking University 302 Hospital


Western Returned Scholars Association/Medical Doctors Association Youth Committee/NIH Chinese Scholarship Association Asia-Pacific Alliance of Liver Diseases (APALD)

Asia-Pacific Alliance of Liver Diseases Association

Tsinghua University / Center for Synthetic and Systems Biology (CSSB)

Beijing Medical Association/Liver disease Branch


About Conference

Dear Colleagues,
The 2018 Beijing Liver Cancer International Conference (BLCIC) will be held from 2 to 4 Novemver 2018, Beijing, China. This forum will cover issues on surgical treatment, medical treatment, minimally invasive or radiotherapy and interventional therapy, specific nursing and translational medicine research of Hepatobiliary Malignancies. We are delighted to invite you to submit or recommend original research papers to this conference through our Paper Submission System.


1) Surgical treatment of Hepatobiliary Malignancies  

2Liver Cancer Prevention and Early Screening  

3) Immunotherapy and Targeted therapy for

4) Minimally Invasive, Interventional Therapy and Radiotherapy of Liver Cancer

5) Translational Researches of Liver Cancer

6) Specific Nursing of Liver Cancer


Honorary Chairmen

1,Qimin Zhan

Academician, Peking University

2,Edward L. Trimble

Founding Director, Center for Global Health (CGH), NCI, NIH


Presiding Chairmen

1,ZHANG Ning

Vice President, Peking University Health Science Center

2,LU Yinying:

Vice Chairman, Molecular Diagnostic Committee




1,WANG Hongyang:

Academician, Chinese Academy of EngineeringDirector

2,DONG Jiahong:

Academician, Beijing Tsinghua Changgung Hospital

3,QIN Shukui:

Deputy Dean, 81 hospital of PLA /Board, CSCO

4,ZHAO Jingmin:

Chairman, Molecular Diagnostic Committee, Chinese Research Hospital Association


5,WANG Xinwei:

Deputy Chief Laboratory of Human Carcinogenesis, NCI, NIH

6,Ghassan Abou-Alfa:

Chief Expert, Memorial Sloan Kettering Cancer Center, America

7,Makuuchi Masatoshi:

Dean, Japan Red Cross Society Medical Center/ Board,  IASGO

8,Bin Gao:

Tenured Senior Investigator, Laboratory of Liver Diseases, NIAAA, NIH

9,Ruyi He:

Chief Scientist, National Drug Review Center, CFDA

10,Leonard M. Neckers:

Senior Investigator, NCI, NIH

A total of 41 reporters attended the meeting.

Key Dates

Conference Date:

November 24 , 2018

Abstract Submission Deadline:

September 10, 2018

Online Registration Deadline:

October 31, 2018

On-site Registration Date:

November 24, 2018

Contact us


  • 2018 Beijing Liver Cancer International Conference Committee
  • Address:NO. 100, West 4th Ring Road, Fengtai District, Beijing, China.
  • Phone:010-66933430
  • Zip:100039
  • Email:This email address is being protected from spambots. You need JavaScript enabled to view it.


Welcome to submit summaries, the summaries can be downloaded from Canada and Medicine(IF = 5). We will invite the authors of the excellent summaries to speak at the conference.